ATE544854T1 - Mutante g-protein-gekoppelte rezeptoren und selektionsverfahren dafür - Google Patents

Mutante g-protein-gekoppelte rezeptoren und selektionsverfahren dafür

Info

Publication number
ATE544854T1
ATE544854T1 AT08718823T AT08718823T ATE544854T1 AT E544854 T1 ATE544854 T1 AT E544854T1 AT 08718823 T AT08718823 T AT 08718823T AT 08718823 T AT08718823 T AT 08718823T AT E544854 T1 ATE544854 T1 AT E544854T1
Authority
AT
Austria
Prior art keywords
gpcr
ligand
mutant
protein
binding
Prior art date
Application number
AT08718823T
Other languages
English (en)
Inventor
Richard Henderson
Christopher Tate
Francesca Magnani
Maria Josefa Serrano-Vega
Yoko Shibata
Anthony Warne
Malcolm Weir
Original Assignee
Heptares Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0705450A external-priority patent/GB0705450D0/en
Priority claimed from GB0724052A external-priority patent/GB0724052D0/en
Application filed by Heptares Therapeutics Ltd filed Critical Heptares Therapeutics Ltd
Application granted granted Critical
Publication of ATE544854T1 publication Critical patent/ATE544854T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT08718823T 2007-03-22 2008-03-20 Mutante g-protein-gekoppelte rezeptoren und selektionsverfahren dafür ATE544854T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0705450A GB0705450D0 (en) 2007-03-22 2007-03-22 Mutant proteins and method for selecting them
GB0724052A GB0724052D0 (en) 2007-12-08 2007-12-08 Mutant proteins and methods for selecting them
PCT/GB2008/000986 WO2008114020A2 (en) 2007-03-22 2008-03-20 Mutant g-protein coupled receptors and methods for selecting them

Publications (1)

Publication Number Publication Date
ATE544854T1 true ATE544854T1 (de) 2012-02-15

Family

ID=39386585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08718823T ATE544854T1 (de) 2007-03-22 2008-03-20 Mutante g-protein-gekoppelte rezeptoren und selektionsverfahren dafür

Country Status (14)

Country Link
US (7) US8785135B2 (de)
EP (4) EP2386635A3 (de)
JP (6) JP4842400B2 (de)
CN (2) CN103641908A (de)
AT (1) ATE544854T1 (de)
AU (1) AU2008228085B2 (de)
CA (1) CA2681415C (de)
DK (1) DK2121919T3 (de)
ES (2) ES2381780T3 (de)
GB (4) GB2456236B8 (de)
HR (1) HRP20120336T1 (de)
PL (1) PL2121919T3 (de)
PT (1) PT2121919E (de)
WO (1) WO2008114020A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008228085B2 (en) 2007-03-22 2011-12-08 Nxera Pharma Uk Limited Mutant G-protein coupled receptors and methods for selecting them
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) * 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
GB201014715D0 (en) 2010-09-06 2010-10-20 Vib Vzw Nanobodies stabilizing functional conformational states of GPCRS
WO2012022928A2 (en) 2010-08-20 2012-02-23 Heptares Therapeutic Ltd Biological materials and uses thereof
WO2012098413A1 (en) * 2011-01-21 2012-07-26 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
KR101963914B1 (ko) 2011-02-23 2019-03-29 매사추세츠 인스티튜트 오브 테크놀로지 수용성 막 단백질 및 이의 제조 방법 및 이의 사용 방법
WO2012120315A2 (en) 2011-03-10 2012-09-13 Heptares Therapeutics Limited Mutant proteins and methods for producing them
DK2742066T3 (en) * 2011-08-10 2018-03-05 Heptares Therapeutics Ltd STABLE PROTEINS
ES2676827T3 (es) 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
PL2951201T3 (pl) 2013-01-30 2018-03-30 Vib Vzw Nowe polipeptydy chimeryczne do celów badań przesiewowych i odkrywania leków
EP2970425B1 (de) 2013-03-15 2019-10-30 United Kingdom Research and Innovation Mutierte membranproteine und verfahren zu deren herstellung
WO2014176544A1 (en) * 2013-04-25 2014-10-30 The Trustees Of The University Of Pennsylvania Water soluble g-protein coupled receptor
US10809222B2 (en) 2013-04-25 2020-10-20 The Trustees Of The University Of Pennsylvania Opioid detection based on high quality graphene transistor arrays and a synthetic mu receptor
EP3008083B1 (de) * 2013-06-11 2021-06-30 Paul Scherrer Institut Verfahren zur bestimmung einer mutierbaren liganden-gpcr zur bindung an eine einzelne aminosäurelösung sowie paare von mutierten liganden und gpcr
US10373702B2 (en) 2014-03-27 2019-08-06 Massachusetts Institute Of Technology Water-soluble trans-membrane proteins and methods for the preparation and use thereof
CN104151401A (zh) * 2014-06-05 2014-11-19 维亚生物科技(上海)有限公司 融合表达离子通道蛋白及运输蛋白的方法及其使用的蛋白片断
GB2527286A (en) 2014-06-11 2015-12-23 Rsr Ltd Glycoprotein hormone receptor mutations
US10287349B2 (en) 2014-10-31 2019-05-14 Abilita Bio, Inc. Modified membrane spanning proteins and methods for the preparation and use thereof
US11618777B2 (en) 2015-07-31 2023-04-04 Shigeyuki Yokoyama Method of manufacturing membrane protein and utilization thereof
GB201601690D0 (en) 2016-01-29 2016-03-16 Heptares Therapeutics Ltd G proteins
EP3205450A1 (de) * 2016-02-09 2017-08-16 Hermes Schleifkörper GmbH Verfahren zur herstellung eines keramischen formkörpers
US10845367B2 (en) 2016-05-04 2020-11-24 Abilita Bio, Inc. Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents
CN109553687B (zh) * 2017-09-27 2021-07-06 北京大学 基于g蛋白偶联受体构建的荧光探针
US12123814B1 (en) * 2019-06-14 2024-10-22 Pierce Biotechnology, Inc. G- protein coupled receptor extraction formulations
IL303865A (en) 2020-12-23 2023-08-01 Regeneron Pharma Methods for obtaining antibodies that bind transmembrane proteins and cells that produce them
CN114038498B (zh) * 2022-01-06 2022-03-18 北京晶泰科技有限公司 Gpcr的热稳定性突变预测方法、结构筛选方法及其装置
CN120948816B (zh) * 2025-10-20 2026-03-03 国科大杭州高等研究院 一种g蛋白偶联受体的热稳定性突变位点筛选方法及其用途

Family Cites Families (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) * 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) * 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6780613B1 (en) * 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
US5750373A (en) 1990-12-03 1998-05-12 Genentech, Inc. Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
WO1990004788A1 (en) 1988-10-28 1990-05-03 Genentech, Inc. Method for identifying active domains and amino acid residues in polypeptides and hormone variants
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
EP0585287B1 (de) 1990-07-10 1999-10-13 Cambridge Antibody Technology Limited Verfahren zur herstellung von spezifischen bindungspaargliedern
DK1820858T3 (da) 1991-03-01 2009-11-02 Dyax Corp Kimært protein omfatende mikroprotein med to eller flere disulfidbindinger og udförelsesformer deraf
JP3147916B2 (ja) * 1991-03-08 2001-03-19 森永製菓株式会社 体外免疫方法
WO1992018619A1 (en) 1991-04-10 1992-10-29 The Scripps Research Institute Heterodimeric receptor libraries using phagemids
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
US20030036092A1 (en) * 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
EP0644935A1 (de) * 1992-06-12 1995-03-29 Garvan Institute Of Medical Research DNA SEQUENZEN KODIERENDE FÜR DIE HUMANEN A1, A2a UND A2b-ADENOSINREZEPTOREN
US5585277A (en) * 1993-06-21 1996-12-17 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
JPH10500951A (ja) 1994-05-23 1998-01-27 スミスクライン・ビーチャム・コーポレイション コードされた組合せライブラリー
US20020028443A1 (en) * 1999-09-27 2002-03-07 Jay M. Short Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process
EP0906339A2 (de) 1996-03-27 1999-04-07 NG, Gordon, Y., K. Antagonisten von rezeptoren und transportmolekülen
CA2250975A1 (en) * 1996-04-15 1997-10-23 The Board Of Trustees Of The Leland Stanford Junior University Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
US6153410A (en) * 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
WO1999051773A1 (en) * 1998-04-03 1999-10-14 Phylos, Inc. Addressable protein arrays
WO1999051777A2 (en) 1998-04-06 1999-10-14 Bunsen Rush Laboratories, Inc. Directed evolution biosensors
US6692696B1 (en) 1998-06-18 2004-02-17 ARETé ASSOCIATES Biosensor
AU756244B2 (en) * 1998-09-01 2003-01-09 Basf Aktiengesellschaft Methods for improving the function of heterologous G protein-coupled receptors
US7094593B1 (en) * 1998-09-01 2006-08-22 Basf Aktiengesellschaft Method for improving the function of heterologous G protein-coupled receptors
AU4847600A (en) 1999-05-14 2000-12-05 Repliscent, Inc. G-protein coupled receptor (gpcr) based biosensors and sense replication systems
WO2001036471A2 (en) 1999-11-17 2001-05-25 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
MXPA02007730A (es) 2000-02-09 2002-10-11 Human Genome Sciences Inc Receptor de quimiocina de proteina g humana (ccr5) hdgnr10.
US7678539B2 (en) 2000-08-10 2010-03-16 Corning Incorporated Arrays of biological membranes and methods and use thereof
WO2002018590A2 (en) * 2000-08-30 2002-03-07 John Hopkins University School Of Medicine Identification of activated receptors and ion channels
US6448377B1 (en) * 2000-09-27 2002-09-10 The Board Of Trustees Of The Leland Stanford Junior University Modified G protein sunbunits
CA2425149A1 (en) * 2000-10-26 2002-08-01 New England Medical Center Hospitals, Inc. Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents
US20030232331A1 (en) * 2000-12-05 2003-12-18 Casman Stacie J. Novel proteins and nucleic acids encoding same
US20030171541A1 (en) * 2001-02-14 2003-09-11 Amgen Inc., A Corporation Of The State Of Delaware G-protein coupled receptor molecules and uses thereof
CA2439383A1 (en) * 2001-02-26 2002-09-06 Arena Pharmaceuticals, Inc. Endogenous and non-endogenous versions of human g protein-coupled receptors
US7208279B2 (en) * 2001-03-14 2007-04-24 Caden Biosciences, Inc. Method for identifying inhibitors of G protein coupled receptor signaling
US7294472B2 (en) 2001-03-14 2007-11-13 Caden Biosciences Method for identifying modulators of G protein coupled receptor signaling
JPWO2002079784A1 (ja) 2001-03-30 2004-07-22 サントリー株式会社 Ｇ蛋白質結合型レセプターの構造モデルおよび当該構造モデルを用いたｇ蛋白質結合型レセプターに結合するリガンドの設計方法
US20030129649A1 (en) * 2001-04-24 2003-07-10 Kobilka Brian K. Conformational assays to detect binding to G protein-coupled receptors
US20050009204A1 (en) 2003-07-11 2005-01-13 Ye Fang Multiplexed binding assays for receptor arrays
DE02770119T1 (de) 2001-10-25 2005-05-04 Astex Technology Ltd Kristalle von cytochrome p450 2c9, strukturen und verwendung davon
US7115377B2 (en) * 2001-10-26 2006-10-03 Atto Bioscience, Inc. Cell-based assays for G-protein-coupled receptor-mediated activities
JP2004238384A (ja) * 2002-03-28 2004-08-26 Takeda Chem Ind Ltd 新規スクリーニング方法
AU2003227268A1 (en) 2002-03-28 2003-10-13 Takeda Chemical Industries, Ltd. Novel screening method
AU2003227358A1 (en) * 2002-04-24 2003-11-10 Banyu Pharmaceutical Co., Ltd. Histamine receptor h3 ordinary activity mutant and utilization thereof
EP1549318B1 (de) * 2002-05-01 2010-02-17 Vertex Pharmaceuticals Incorporated Kristallstruktur des aurora-2 proteins und dessen bindungstaschen
EP1581648A2 (de) * 2002-09-09 2005-10-05 Nura, Inc. G-protein-gekoppelte rezeptoren und deren verwendung
AU2002951995A0 (en) * 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
US20040096914A1 (en) 2002-11-20 2004-05-20 Ye Fang Substrates with stable surface chemistry for biological membrane arrays and methods for fabricating thereof
ATE500270T1 (de) * 2003-05-20 2011-03-15 Univ Glasgow Materialien und methoden die sich auf g-protein gekoppelte rezeptor oligomere beziehen
US7745161B2 (en) * 2003-12-19 2010-06-29 Palo Alto Research Center Incorporated Amplification of enzymatic reactions for use with an enthalpy array
WO2005109001A2 (en) * 2004-05-12 2005-11-17 Galapagos N.V. Methods, compositions and compound assays for inhibiting amyloid-beta protein production
WO2005121755A1 (en) 2004-06-14 2005-12-22 Commonwealth Scientific And Industrial Research Organisation Cell free g-protein coupled receptor and ligand assay
WO2006023248A2 (en) 2004-07-28 2006-03-02 The Trustees Of Columbia University In The City Of New York Processes for producing and crystallizing g-protein coupled receptors
JP2006340717A (ja) * 2005-05-11 2006-12-21 Sekisui Chem Co Ltd Ｇタンパク質共役型受容体に対する結合性評価方法及び評価用組成物、融合タンパク質、並びに、遺伝子
FR2890174B1 (fr) 2005-08-30 2009-04-24 Cis Bio Internat Sa Procede pour la mise en evidence d'un processus biologique par mesure d'un fret
US20070154947A1 (en) * 2005-08-31 2007-07-05 The Trustees Of Princeton University Chemical biodiscriminator
EP1948232A4 (de) * 2005-11-18 2010-09-22 Univ Ohio State Res Found Virale genprodukte und verfahren zur schutzimpfung vor viruserkrankungen
US7495024B2 (en) * 2006-08-07 2009-02-24 Via Pharmaceuticals, Inc. Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque
AU2008228085B2 (en) 2007-03-22 2011-12-08 Nxera Pharma Uk Limited Mutant G-protein coupled receptors and methods for selecting them
WO2009051769A1 (en) 2007-10-17 2009-04-23 The Board Of Trustees Of The Leland Stanford Junior University Method and composition for crystallizing g protein-coupled receptors
CA2701283C (en) 2007-10-22 2014-07-15 The Scripps Research Institute Methods and compositions for obtaining high-resolution crystals of membrane proteins
GB0724051D0 (en) * 2007-12-08 2008-01-16 Medical Res Council Mutant proteins and methods for producing them
GB0724860D0 (en) 2007-12-20 2008-01-30 Heptares Therapeutics Ltd Screening
GB0802474D0 (en) * 2008-02-11 2008-03-19 Heptares Therapeutics Ltd Mutant proteins and methods for selecting them
US20110112037A1 (en) * 2008-03-05 2011-05-12 Heptares Therapeutics Limited BioPark Crystal structure
GB0910725D0 (en) * 2009-06-22 2009-08-05 Heptares Therapeutics Ltd Mutant proteins and methods for producing them
WO2012022928A2 (en) 2010-08-20 2012-02-23 Heptares Therapeutic Ltd Biological materials and uses thereof
WO2012030735A1 (en) 2010-08-30 2012-03-08 Confometrx, Inc. Method and composition for crystallizing a family c gpcr
WO2012098413A1 (en) 2011-01-21 2012-07-26 Heptares Therapeutics Limited Mutant g-protein coupled receptor proteins and methods for producing them
AU2012256101A1 (en) 2011-05-13 2013-10-24 Receptos, Inc. Novel fusion partners for the purpose of crystallizing G-protein coupled receptors
DK2742066T3 (en) 2011-08-10 2018-03-05 Heptares Therapeutics Ltd STABLE PROTEINS
EP2617732A1 (de) 2012-01-19 2013-07-24 Vib Vzw Werkzeuge und Verfahren zur Expression von Membranproteinen
WO2013142278A1 (en) 2012-03-22 2013-09-26 New York University Plasmodium vivax vaccine compositions
ES2676827T3 (es) 2012-06-01 2018-07-25 Heptares Therapeutics Limited Ensayos
US20150359869A1 (en) 2012-08-15 2015-12-17 Cyvax, Inc. Methods and compositions for preventing a condition
US20150261911A1 (en) 2014-03-13 2015-09-17 Heptares Therapeutics Limited Crystal structure

Also Published As

Publication number Publication date
PT2121919E (pt) 2012-05-17
DK2121919T3 (da) 2012-05-21
AU2008228085A1 (en) 2008-09-25
JP2018164456A (ja) 2018-10-25
CA2681415C (en) 2020-11-03
US20180086814A1 (en) 2018-03-29
JP2010521983A (ja) 2010-07-01
CN103641908A (zh) 2014-03-19
GB2456236A (en) 2009-07-15
EP3926045A1 (de) 2021-12-22
US20120270230A1 (en) 2012-10-25
CN101688203A (zh) 2010-03-31
EP2121919B1 (de) 2012-02-08
WO2008114020A2 (en) 2008-09-25
US20160052991A1 (en) 2016-02-25
WO2008114020A9 (en) 2010-03-11
GB2447786C (en) 2011-11-09
GB2456235B (en) 2009-10-28
JP7419217B2 (ja) 2024-01-22
EP2386635A3 (de) 2012-02-08
JP4842400B2 (ja) 2011-12-21
GB0901111D0 (en) 2009-03-11
EP3926045B1 (de) 2025-01-01
ES3008359T3 (en) 2025-03-24
CN101688203B (zh) 2013-12-11
JP2016187348A (ja) 2016-11-04
US20100190188A1 (en) 2010-07-29
JP6426661B2 (ja) 2018-11-21
US20210061882A1 (en) 2021-03-04
EP3926045C0 (de) 2025-01-01
HRP20120336T1 (hr) 2012-05-31
US11673938B2 (en) 2023-06-13
JP2011224018A (ja) 2011-11-10
GB2456235B8 (en) 2009-12-09
WO2008114020A3 (en) 2009-03-19
AU2008228085B2 (en) 2011-12-08
GB2456235A (en) 2009-07-15
EP2386635A2 (de) 2011-11-16
EP2450445A1 (de) 2012-05-09
US20190241644A1 (en) 2019-08-08
PL2121919T3 (pl) 2012-07-31
GB2456237B (en) 2009-10-28
GB2447786B (en) 2009-11-11
JP2021036901A (ja) 2021-03-11
EP2121919A2 (de) 2009-11-25
US20240052017A1 (en) 2024-02-15
GB0901095D0 (en) 2009-03-11
GB2456236B8 (en) 2009-12-09
GB2447786A (en) 2008-09-24
ES2381780T3 (es) 2012-05-31
US8785135B2 (en) 2014-07-22
GB0901110D0 (en) 2009-03-11
GB2456237A (en) 2009-07-15
GB0805267D0 (en) 2008-04-30
CA2681415A1 (en) 2008-09-25
JP2014155502A (ja) 2014-08-28
GB2456236B (en) 2009-10-28
GB2456237B8 (en) 2009-12-09

Similar Documents

Publication Publication Date Title
ATE544854T1 (de) Mutante g-protein-gekoppelte rezeptoren und selektionsverfahren dafür
WO2009081136A3 (en) Screening
ATE544870T1 (de) Profilierung einer rezeptorfamilie
EP2650009B8 (de) Screeningverfahren mit G-Protein-gekoppelten Rezeptoren und entsprechende Zusammensetzungen
WO2009071914A3 (en) Mutant proteins and methods for producing them
NO20065417L (no) Muskarine acetylkolinreceptorantagonister
DK2049478T3 (da) Substituerede N-phenylmethyl-5-oxoprolin-2-amider som P2X7-receptorantagonister og fremgangsmåder til anvendelse deraf
EP2151236A4 (de) G-protein-konjugierter rezeptoragonist
TN2009000181A1 (en) Agonist trkb antibodies and uses thereof
WO2007092938A3 (en) Cellular assays for signaling receptors
NO20060775L (no) Muskarine acetylkolinreseptorantagonister
WO2010040003A3 (en) Human a2a adenosine receptor crystals and uses thereof
DK2189539T3 (da) Konjugatkomplekser til analytdetektering
WO2007136838A3 (en) Methods and compositions related to gaba receptor subunits
WO2007115061A3 (en) Bidding for on-line survey placement
WO2008022716A3 (en) Screening method for gpcr ligands
DE602004025812D1 (de) N mammakarzinom
WO2008063797A3 (en) Dynamic help references for software documentation
WO2007028126A3 (en) Methods and systems for identifying insulin mimetics
WO2006119497A3 (en) Acetylycholine gated ion channel chaperons and methods of using the same
Sylas Receptors
WO2008097560A3 (en) Methods for the identification of drugs that interact with the g protein coupled receptor dp
MY149586A (en) Pcr screening method
HK1134502A (en) Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir
Asano On An Evaluation to Academic Achievement in Basic Structural Mechanics